Zur JKU Startseite
Institut für Angewandte Statistik
Was ist das?

Institute, Schools und andere Einrichtungen oder Angebote haben einen Webauftritt mit eigenen Inhalten und Menüs.

Um die Navigation zu erleichtern, ist hier erkennbar, wo man sich gerade befindet.

Detail

Forschungsseminar am Institut für Angewandte Statistik

2. Juni - Andrea Berghold, Institute for Medical Informatics, Medical University of Graz: Longitudinal development of the antibody response against SARS-CoV-2, statistical aspects

zoom link, öffnet eine externe URL in einem neuen Fenster

meeting ID: 937 6054 7545

password: 946296

Abstract pdf, öffnet eine Datei

In the talk the statistical aspects of a study will be presented where time-related changes in the anti-SARS-CoV-2 antibody concentration of a clinically homogeneous cohort of individuals that recovered from a mild course of COVID-19 not requiring hospitalization were investigated.
325 PCR-confirmed COVID-19 convalescent individuals took part in the study at the Medical University of Graz between June 2020 and February 2022. Anti-SARS-CoV-2 pan-Ig antibodies were measured in plasma with a qualitative and quantitative assay at five different time points. Participants filled in a clinical questionnaire about COVID-19 symptoms during the baseline visit. Samples collected after the date of first vaccination were censored. The longitudinal development of the antibody concentration was modeled using three different approaches: 1) Linear Mixed Effect Models; 2) Generalized Additive Mixed Models with a smoothing term; 3) Latent Growth Models with time-invariant and time-varying covariates.
Most of the participants (62% female, median age = 42 years, IQR: 31 – 52) had core symptoms (299/325, 92%), at least one among fever, cough, dyspnea, ageusia and anosmia during the course of the disease. Results of the three statistical approaches were generally consistent and indicated a positive relation between the antibody level and the time since diagnosis. The time between diagnosis and baseline sampling varied notably between subjects (median = 64 days, IQR: 39 - 111) and was controlled for in the statistical analyses. Individuals who came to the baseline visit more than six weeks after diagnosis had higher baseline antibody concentrations, but experienced a lower increase through time as compared to individuals who came to the baseline visit earlier.
Our results reveal an enduring immune response against SARS-CoV-2 in convalescent individuals who underwent a mild course of COVID-19. A relevant source of heterogeneity that should be accounted for in future studies is the time lag between diagnosis and baseline sampling.

Event

Datum & Uhrzeit

02.06.2022

15:30 - 17:00 Uhr

Meinem Kalender hinzufügen

Ort

S2 Z74, Science Park 2

Kontakt

milan.stehlik@jku.at